Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 SuppressionThe New England journal of medicine, 2020-03, Vol.382 (12), p.1112-1123 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1904398 ;PMID: 32130809Full text available |
|
2 |
Material Type: Article
|
Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 InfectionThe New England journal of medicine, 2020-03, Vol.382 (12), p.1124-1135 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1909512 ;PMID: 32130806Full text available |
|
3 |
Material Type: Article
|
Medication adherence influencing factors-an (updated) overview of systematic reviewsSystematic reviews, 2019-05, Vol.8 (1), p.112-112, Article 112 [Peer Reviewed Journal]2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 2046-4053 ;EISSN: 2046-4053 ;DOI: 10.1186/s13643-019-1014-8 ;PMID: 31077247Full text available |
|
4 |
Material Type: Article
|
The difficulties experienced during the preparation and administration of oral drugs by parents at home: a cross-sectional study from PalestineBMC pediatrics, 2020-05, Vol.20 (1), p.198-8, Article 198 [Peer Reviewed Journal]COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2431 ;EISSN: 1471-2431 ;DOI: 10.1186/s12887-020-02105-w ;PMID: 32381063Full text available |
|
5 |
Material Type: Article
|
Liquid Medication Errors and Dosing Tools: A Randomized Controlled ExperimentPediatrics (Evanston), 2016-10, Vol.138 (4), p.1 [Peer Reviewed Journal]Copyright © 2016 by the American Academy of Pediatrics. ;Copyright American Academy of Pediatrics Oct 2016 ;Copyright © 2016 by the American Academy of Pediatrics 2016 ;ISSN: 0031-4005 ;EISSN: 1098-4275 ;DOI: 10.1542/peds.2016-0357 ;PMID: 27621414 ;CODEN: PEDIAUFull text available |
|
6 |
Material Type: Article
|
Intestinal Absorption Study: Challenges and Absorption Enhancement Strategies in Improving Oral Drug DeliveryPharmaceuticals (Basel, Switzerland), 2022-08, Vol.15 (8), p.975 [Peer Reviewed Journal]COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 1424-8247 ;EISSN: 1424-8247 ;DOI: 10.3390/ph15080975 ;PMID: 36015123Full text available |
|
7 |
Material Type: Article
|
Mucoadhesive Budesonide Solution for the Treatment of Pediatric Eosinophilic EsophagitisPharmaceuticals (Basel, Switzerland), 2024-05, Vol.17 (5), p.550 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1424-8247 ;EISSN: 1424-8247 ;DOI: 10.3390/ph17050550 ;PMID: 38794121Full text available |
|
8 |
Material Type: Article
|
A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two yearsPloS one, 2022-11, Vol.17 (11), p.e0272241-e0272241 [Peer Reviewed Journal]COPYRIGHT 2022 Public Library of Science ;2022 Vickery et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Vickery et al 2022 Vickery et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0272241 ;PMID: 36399463Full text available |
|
9 |
Material Type: Article
|
Oral hymecromone decreases hyaluronan in human study participantsThe Journal of clinical investigation, 2022-05, Vol.132 (9), p.1-9 [Peer Reviewed Journal]COPYRIGHT 2022 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation May 2022 ;2022 Rosser et al. 2022 Rosser et al. ;ISSN: 1558-8238 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI157983 ;PMID: 35499083Full text available |
|
10 |
Material Type: Article
|
Systematic Review of the Toxicity of Long-Course Oral Corticosteroids in ChildrenPloS one, 2017-01, Vol.12 (1), p.e0170259 [Peer Reviewed Journal]COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Aljebab et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Aljebab et al 2017 Aljebab et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0170259 ;PMID: 28125632Full text available |
|
11 |
Material Type: Article
|
Turing milk into pro-apoptotic oral nanotherapeutic: De novo bionic chiral-peptide supramolecule for cancer targeted and immunological therapyTheranostics, 2022-01, Vol.12 (5), p.2322-2334 [Peer Reviewed Journal]The author(s). ;2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The author(s) 2022 ;ISSN: 1838-7640 ;EISSN: 1838-7640 ;DOI: 10.7150/thno.70568 ;PMID: 35265212Full text available |
|
12 |
Material Type: Article
|
PredAOT: a computational framework for prediction of acute oral toxicity based on multiple random forest modelsBMC bioinformatics, 2023-02, Vol.24 (1), p.66-66, Article 66 [Peer Reviewed Journal]2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2105 ;EISSN: 1471-2105 ;DOI: 10.1186/s12859-023-05176-5 ;PMID: 36829107Full text available |
|
13 |
Material Type: Article
|
Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/RitonavirViruses, 2022-11, Vol.14 (11), p.2540 [Peer Reviewed Journal]COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v14112540 ;PMID: 36423149Full text available |
|
14 |
Material Type: Article
|
Administration of oral dosage forms of medicines to children in a resource limited settingPloS one, 2022-12, Vol.17 (12), p.e0276379-e0276379 [Peer Reviewed Journal]Copyright: © 2022 Nadeshkumar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2022 Public Library of Science ;2022 Nadeshkumar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Nadeshkumar et al 2022 Nadeshkumar et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0276379 ;PMID: 36548310Full text available |
|
15 |
Material Type: Article
|
Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and PerspectivesBioMed research international, 2021-12, Vol.2021, p.6618934-12 [Peer Reviewed Journal]Copyright © 2021 Mohammadali Poursharifi Ghourichay et al. ;COPYRIGHT 2021 Hindawi Limited ;Copyright © 2021 Mohammadali Poursharifi Ghourichay et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;Copyright © 2021 Mohammadali Poursharifi Ghourichay et al. 2021 ;ISSN: 2314-6133 ;EISSN: 2314-6141 ;DOI: 10.1155/2021/6618934 ;PMID: 34977245Full text available |
|
16 |
Material Type: Article
|
Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism – The SWAN StudyPloS one, 2020-06, Vol.15 (6), p.e0234048-e0234048 [Peer Reviewed Journal]COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Hendriks et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Hendriks et al 2020 Hendriks et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0234048 ;PMID: 32497116Full text available |
|
17 |
Material Type: Article
|
Investigation of oral macrolide prescriptions in Japan using a retrospective claims database, 2013-2018PloS one, 2023-06, Vol.18 (6), p.e0287297-e0287297 [Peer Reviewed Journal]Copyright: © 2023 Ide et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2023 Public Library of Science ;2023 Ide et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Ide et al 2023 Ide et al ;2023 Ide et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0287297 ;PMID: 37347735Full text available |
|
18 |
Material Type: Article
|
A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropeniaPloS one, 2019-03, Vol.14 (3), p.e0212837 [Peer Reviewed Journal]COPYRIGHT 2019 Public Library of Science ;COPYRIGHT 2019 Public Library of Science ;2019 Arrieta et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Arrieta et al 2019 Arrieta et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0212837 ;PMID: 30913226Full text available |
|
19 |
Material Type: Article
|
Online searches of children’s oseltamivir in public primary and specialized care: Detecting influenza outbreaks in Finland using dedicated databases for health care professionalsPloS one, 2022-08, Vol.17 (8), p.e0272040-e0272040 [Peer Reviewed Journal]COPYRIGHT 2022 Public Library of Science ;2022 Mukka et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Mukka et al 2022 Mukka et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0272040 ;PMID: 35930527Full text available |
|
20 |
Material Type: Article
|
Methylene blue for intractable pain from oral mucositis related to cancer treatment: a randomized phase 2 clinical trialBMC medicine, 2022-11, Vol.20 (1), p.1-377, Article 377 [Peer Reviewed Journal]COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-022-02579-8Full text available |